Can anti-tumor necrosis factor agents be discontinued in patients with inflammatory bowel disease?

Jihye Park; Jae Hee Cheon

doi:10.5009/gnl210345

Can anti-tumor necrosis factor agents be discontinued in patients with inflammatory bowel disease?

Department of Internal Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	641-642
Number of pages	2
Journal	Gut and liver
Volume	15
Issue number	5
DOIs	https://doi.org/10.5009/gnl210345
Publication status	Published - 2021 Sept

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology

Access to Document

10.5009/gnl210345

Cite this

@article{9c210798d9f1465c8dce475deb82de36,

title = "Can anti-tumor necrosis factor agents be discontinued in patients with inflammatory bowel disease?",

author = "Jihye Park and Cheon, {Jae Hee}",

year = "2021",

month = sep,

doi = "10.5009/gnl210345",

language = "English",

volume = "15",

pages = "641--642",

journal = "Gut and Liver",

issn = "1976-2283",